Effect of Oral Supplementation With Probiotics

NCT03100162 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-05-06

No results posted yet for this study

Summary

Effect of oral supplementation with probiotics on cardiometabolic risk factors, microflora and intestinal epithelial permeability, mineral content and lifestyle in obese women with postmenopausal metabolic syndrome: double-blind, randomized clinical trial.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)

    collaborator UNKNOWN
  • Poznan University of Life Sciences

    collaborator OTHER
  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Pawel Bogdanski, MD PhD · Poznan University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-27
Primary Completion
2018-01-04
Completion
2018-02-02

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03100162 on ClinicalTrials.gov